Vericel Corp of BURLINGTON, MA filed a DEFA14A with the SEC on 2026-03-19. Industry: Biological Products, (No Diagnostic Substances).
| Seq | Type | Description |
|---|---|---|
| 1 | DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| 2 | GRAPHIC | GRAPHIC |
| 3 | GRAPHIC | GRAPHIC |
| 4 | GRAPHIC | GRAPHIC |
| 5 | GRAPHIC | GRAPHIC |
| 6 | GRAPHIC | GRAPHIC |
| 7 | GRAPHIC | GRAPHIC |
| 8 | GRAPHIC | GRAPHIC |
| 9 | GRAPHIC | GRAPHIC |
| 10 | GRAPHIC | GRAPHIC |
| 11 | GRAPHIC | GRAPHIC |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2026-03-19 | DEFA14A |
| 2026-03-19 | DEF 14A |
| 2025-03-20 | DEFA14A |
| 2025-03-20 | DEF 14A |
| 2024-03-21 | DEFA14A |
| 2024-03-21 | DEF 14A |
| 2023-03-23 | DEFA14A |
| 2023-03-23 | DEF 14A |
| 2022-03-17 | DEFA14A |
| 2022-03-17 | DEF 14A |
| 2021-03-19 | DEFA14A |
| 2021-03-19 | DEF 14A |